Trials / Completed
CompletedNCT00749372
MRI Screening for Patients With Myelodysplastic Syndrome (MDS), Who Have Received Multiple Red Blood Cell Transfusions
T2* Cardiac MRI Screening of Highly Transfused Patients With Myelodysplastic Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Weill Medical College of Cornell University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A known risk of red blood cell transfusions is that it puts excess iron into the patient's body. Researchers are continually seeking the most effective method of measuring iron concentration. The purpose of this study is to determine how much iron has been deposited in a patient's heart and liver as a result of having received red blood cell transfusions using magnetic resonance imaging (MRI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | T2* Cardiac and Liver MRI | Patients will undergo an MRI of the heart and liver. |
Timeline
- Start date
- 2008-07-31
- Primary completion
- 2013-03-29
- Completion
- 2013-03-29
- First posted
- 2008-09-09
- Last updated
- 2018-10-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00749372. Inclusion in this directory is not an endorsement.